Biotech

All Articles

Bicara, Zenas seek IPOs to press late-phase possessions towards market

.Bicara Rehabs and also Zenas Biopharma have actually provided new catalyst to the IPO market along ...

Genentech to close cancer immunology analysis division

.Genentech will certainly shut its cancer cells immunology study department, and unit mind as well a...

Kezar drops solid tumor however to prove its own worth in stage 1 trial

.Kezar Lifestyle Sciences is actually dropping its dim stage 1 strong growth drug as the biotech goe...

Acelyrin loses izokibep, lets go 3rd of workers

.Even with izokibep sustaining its own newfound winning streak in the clinic, Acelyrin is actually n...

Rivus' phase 2 obesity-related heart failure trial strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing medi...

Ovid standstills preclinical job, IV course after soticlestat fall short

.Ovid Therapeutics already showed final month that it was trimming back its own headcount as the pro...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Seaport, boosting its ...

Boundless Bio creates 'small' unemployments five months after $100M IPO

.Only 5 months after safeguarding a $100 thousand IPO, Vast Biography is presently laying off some w...

Halda's $126M will certainly advance 'secure as well as eliminate' lump drugs

.The preliminary stages of oncology R&ampD may not be short of intriguing brand new methods, as well...

Lykos 'disappointments' certainly not making known research study transgressions along with author

.Psychopharmacology has actually taken 3 short articles concerning midstage medical test records ana...